Peptides

Pentadeca Arginate (PDA)

Evidence: animal_plus_anecdotal

Mechanism of Action

Pentadeca Arginate is a synthetic 15-amino acid peptide utilizing an arginate salt formulation of the BPC-157 sequence, designed to enhance nitric oxide production and promote angiogenesis. It stimulates collagen synthesis, enhances tissue repair through increased tensile strength, reduces inflammation via modulation of inflammatory cytokines, and accelerates cellular proliferation in tendon fibroblasts. The arginate salt form provides superior stability and bioavailability compared to traditional acetate formulations.

Dosing Protocol

Standard: Research indicates 250-500 mcg administered 1-2 times daily via subcutaneous injection.

Maintenance: Research indicates 250 mcg daily for maintenance protocols.

Administration: subcutaneousintramuscularoral

Timing: Administer on an empty stomach. Inject near site of injury for localized effect.

Duration: 4-12 weeks depending on therapeutic target.

Notes

PDA emerged as an alternative to BPC-157 following FDA regulatory scrutiny. The arginate salt provides enhanced oral bioavailability (claimed 7-fold improvement over acetate in rat studies) and superior acid stability. Preclinical studies show enhanced efficacy in Achilles tendon, MCL, and quadriceps tendon repair models. However, the evidence base is predominantly preclinical and the PDA-specific formulation has limited published peer-reviewed data.

Stacking

  • TB-500
  • GHK-Cu
  • CJC-1295/Ipamorelin

Interactions

  • BPC-157 (acetate) [LOW] — PDA is essentially an improved formulation of BPC-157; do not stack with standard BPC-157 as they share the same active sequence.
  • NSAIDs [LOW] — Generally complementary for recovery protocols.

Contraindications

  • Active cancer
  • Pregnancy and breastfeeding
  • Children under 18

Side Effects

  • Mild nausea (rare)
  • Injection site irritation
  • Headache (uncommon)

Key Papers

  • 10.1016/j.lfs.2018.07.004
  • 10.1038/s41598-020-74022-y

Source Quality

Compounding pharmacy (503A/503B). The arginate salt form is the distinguishing feature — verify salt form on COA.

Disclaimer: This information is for educational purposes only and is not medical advice. BioAccelera Labs does not diagnose, treat, or prescribe. Consult a licensed healthcare provider before using any compound.

Should Pentadeca Arginate (PDA) Be in Your Stack?

Take the free assessment and get personalized recommendations based on your biology and goals.

Get Your Free Protocolor take the assessment →
← Browse All 231 Compounds